PD-L1 expression has been shown to predict response to various ICIs in head and neck squamous cell carcinoma, triple-negative breast cancer, urothelial carcinoma, and gastric carcinoma [156]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.